Published in Chronic Dis Inj Can on March 01, 2013
Letter to the Editor--long-term analysis of cancer incidence, mortality and survival trends in Canada. Chronic Dis Inj Can (2014) 1.06
Trends in incidence, mortality, and survival for kidney cancer in Canada, 1986-2007. Cancer Causes Control (2014) 0.95
Childhood height and body mass index were associated with risk of adult thyroid cancer in a large cohort study. Cancer Res (2013) 0.94
Epidemiologic characteristics of cervical cancer in Korean women. J Gynecol Oncol (2014) 0.92
Temporal trends in demographics and overall survival of non-small-cell lung cancer patients at Moffitt Cancer Center from 1986 to 2008. Cancer Control (2014) 0.88
Population-level trends in relative survival for cervical cancer. Am J Obstet Gynecol (2015) 0.82
An examination of prostate cancer trends in Australia, England, Canada and USA: Is the Australian death rate too high? World J Urol (2015) 0.81
Cancer mortality in Brazil: Temporal Trends and Predictions for the Year 2030. Medicine (Baltimore) (2015) 0.80
Prostate-Specific Antigen (PSA)-Based Population Screening for Prostate Cancer: An Evidence-Based Analysis. Ont Health Technol Assess Ser (2015) 0.79
Mammary tumour development is dose-dependently inhibited by n-3 polyunsaturated fatty acids in the MMTV-neu(ndl)-YD5 transgenic mouse model. Lipids Health Dis (2014) 0.79
Calcitriol in Combination Therapy for Prostate Cancer: Pharmacokinetic and Pharmacodynamic Interactions. J Cancer (2016) 0.77
A genome wide association study on Newfoundland colorectal cancer patients' survival outcomes. Biomark Res (2015) 0.77
Fucoxanthin and Its Metabolite Fucoxanthinol in Cancer Prevention and Treatment. Mar Drugs (2015) 0.77
Trend Analysis of Cancer Mortality and Incidence in Panama, Using Joinpoint Regression Analysis. Medicine (Baltimore) (2015) 0.75
Small-area spatio-temporal analyses of bladder and kidney cancer risk in Nova Scotia, Canada. BMC Public Health (2016) 0.75
Role of n-3 Polyunsaturated Fatty Acids and Exercise in Breast Cancer Prevention: Identifying Common Targets. Nutr Metab Insights (2016) 0.75
The diagnostic performance of shear wave speed (SWS) imaging for thyroid nodules with elasticity modulus and SWS measurement. Oncotarget (2017) 0.75
Authors' response. Chronic Dis Inj Can (2014) 0.75
Clinical and prognostic factors in 98 patients with malignant melanoma in China. J Int Med Res (2017) 0.75
Epidemiology of contralateral breast cancer. Cancer Epidemiol Biomarkers Prev (1999) 2.74
Increasing thyroid cancer incidence in Canada, 1970-1996: time trends and age-period-cohort effects. Br J Cancer (2001) 2.36
Increased rates of illness and death from asthma in Canada. CMAJ (1987) 2.31
Farming and prostate cancer mortality. Am J Epidemiol (1993) 2.10
Trends in childhood injury mortality in Canada, 1979-2002. Inj Prev (2006) 1.73
Trends by anatomic site in the incidence of cutaneous malignant melanoma in Canada, 1969-93. Cancer Causes Control (1999) 1.58
Periodontal disease and risk of fatal coronary heart and cerebrovascular diseases. J Cardiovasc Risk (1999) 1.51
Premature deaths in Canada: impact, trends and opportunities for prevention. Can J Public Health (1991) 1.42
Mortality on Canadian Indian Reserves 1977-1982. Can J Public Health (1986) 1.42
Liver cirrhosis mortality and per capita alcohol consumption in Canada. Can J Public Health (1992) 1.39
Tobacco, alcohol, asbestos, and nickel in the etiology of cancer of the larynx: a case-control study. J Natl Cancer Inst (1981) 1.30
First analysis of mortality and occupational radiation exposure based on the National Dose Registry of Canada. Am J Epidemiol (1998) 1.29
Socioeconomic status and lung cancer risk in Canada. Int J Epidemiol (2001) 1.28
Cervical cancer: the increasing incidence of adenocarcinoma and adenosquamous carcinoma in younger women. CMAJ (2001) 1.17
Cervical cancer in Canada: changing patterns in incidence and mortality. Int J Gynecol Cancer (2001) 1.16
Cancer patterns in Canada. CMAJ (1986) 1.11
Herbicides and cancer. J Natl Cancer Inst (1992) 1.04
Clues to the aetiological heterogeneity of testicular seminomas and non-seminomas: time trends and age-period-cohort effects. Int J Epidemiol (2000) 1.04
Incidence of second primary breast cancer among women with a first primary in Manitoba, Canada. Breast Cancer Res Treat (2001) 0.99
Study of 'patterns of care' of ovarian cancer patients in a specialized cancer institute in Kolkata, eastern India. Indian J Cancer (2009) 0.95
Survival of women with breast cancer in Ottawa, Canada: variation with age, stage, histology, grade and treatment. Br J Cancer (2004) 0.93
Survival patterns for the top four cancers in Canada: the effects of age, region and period. Eur J Cancer Prev (2005) 0.93
The impact of medical care on mortality in Canada, 1959-1988. Can J Public Health (1991) 0.91
Luteal phase ovarian oestrogen is not essential for implantation and maintenance of pregnancy from surrogate embryo transfer in the rhesus monkey. Hum Reprod (1994) 0.90
Iodopovidone pleurodesis: experience of a tertiary hospital in Kolkata. Singapore Med J (2010) 0.88
Important risk factors for death in adults: a 10-year follow-up of the Nutrition Canada survey cohort. CMAJ (1987) 0.88
Epidemiology of community-acquired meticillin-resistant Staphylococcus aureus obtained from the UK West Midlands region. J Hosp Infect (2008) 0.87
Kidney cancer in Canada: the rapidly increasing incidence of adenocarcinoma in adults and seniors. Can J Public Health (1997) 0.86
Leukemia and residential exposure to radon. Can J Public Health (1993) 0.86
Seasonality in epidemics of asthma mortality and hospital admission rates, Ontario, 1979-86. Can J Public Health (1990) 0.83
Multi detector computed tomography (MDCT) evaluation of small bowel obstruction: pictorial review. Trop Gastroenterol (2011) 0.82
Time trends and sex patterns in Hodgkin's disease incidence in Canada, 1970-1995. Can J Public Health (2000) 0.81
Active and passive smoking and the risk of stomach cancer, by subsite, in Canada. Eur J Cancer Prev (2002) 0.81
HIV-1 and intestinal helminth review update: updating a Cochrane Review and building the case for treatment and has the time come to test and treat? Parasite Immunol (2009) 0.80
Canadian trends in liver cancer: a brief clinical and epidemiologic overview. Curr Oncol (2013) 0.80
A telephone survey to measure risk factor prevalence in communities across Canada. Can J Public Health (1990) 0.80
The effect of oral folic acid on glutathione, glycaemia and lipids in Type 2 diabetes. Diabetes Nutr Metab (2004) 0.79
Euglycaemic diabetic ketoacidosis. Hosp Med (2003) 0.78
Motor vehicle traffic accidents in Canada, 1978-87 by time of occurrence. Can J Public Health (1993) 0.78
Contaminants in drinking water and cancer risks in Canadian cities. Can J Public Health (1987) 0.78
Pasteurella multocida--an uncommon cause of obstetric and gynaecological sepsis. J Infect (1995) 0.77
Effect of RU 486 on the endometrial response to deciduogenic stimulus in ovariectomized rhesus monkeys treated with oestrogen and progesterone. Hum Reprod (1992) 0.77
Hannahpep: A novel fibrinolytic peptide from the Indian King Cobra (Ophiophagus hannah) venom. Biochem Biophys Res Commun (1999) 0.76
Mortality and cancer incidence in a nickel cohort. Occup Med (Lond) (2010) 0.76
Morphoea presenting shortly after the onset of Schmidt's syndrome. Clin Exp Dermatol (2000) 0.75
Relationship of dietary folate and vitamin B6 with coronary heart disease in women. JAMA (1998) 0.75
Authors' response. Chronic Dis Inj Can (2014) 0.75
Of mice and men: the evolution of animal welfare guidelines for cancer research. Br J Cancer (2010) 0.75
Survival rates among patients with cancer in Alberta in 1974-78. CMAJ (1988) 0.75
Neuromyotonia and sinoatrial block. Postgrad Med J (2000) 0.75
Mesothelial reaction in longstanding Crohn's ileitis simulating papillary mesothelioma. J Clin Pathol (2008) 0.75
The prevalence of cancer in Canada. Can J Public Health (1991) 0.75
Aldosterone renin ratio in patients with resistant hypertension. QJM (2010) 0.75
Have diagnostic practices contributed to trends in leukemia incidence and mortality among Canadians? Cancer Prev Control (1999) 0.75
Cells before and after carcinogenesis. Indian J Cancer (1965) 0.75
Community-based mortality surveillance: the Maniwaki experience investigation of excess mortality in a community. Can J Public Health (1985) 0.75
Quantitative differences in mass of normal and malignant cells in their biological phases. Indian J Cancer (1967) 0.75
Quantitative differences in protein and nucleic acid concentrations of normal and malignant stratified epithelia in their biological phases in micromicrograms per square micron of cellular regions. Indian J Pathol Bacteriol (1968) 0.75
Occurrence of a unique protein toxin from the Indian King Cobra (Ophiophagus hannah) venom. Toxicon (2001) 0.75
Recent trends in lung cancer among Canadians ages 25-44. Can J Public Health (1993) 0.75
Incidence of succinic dehydrogenase in the nucleoli of mammalian cells. Indian J Cancer (1967) 0.75
Mortality atlas of Canada: Volume 4--General mortality patterns and recent trends. Health Rep (1991) 0.75
A study on correlation between cardiovascular and neurological manifestations of respiratory failure with arterial O2, CO2 contents and pH of blood. J Indian Med Assoc (1976) 0.75
Luteal phase contraception with mifepristone (RU 486) in the rhesus monkey. Indian J Physiol Pharmacol (1994) 0.75
Vaccine adverse reactions in young children in Ontario. Can J Public Health (1989) 0.75
Contranidatory activity of early luteal phase administration of mifepristone in the rhesus monkey. Indian J Physiol Pharmacol (1993) 0.75